Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
Article
Google Scholar
Pascual S, Herrera I, Irurzun J. New advances in hepatocellular carcinoma. World J Hepatol. 2016;8(9):421–38.
Article
Google Scholar
Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson A 3rd, Nemcek AA Jr, Gates VL, et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology. 2008;47(1):71–81.
Article
Google Scholar
Mornex F, Girard N, Beziat C, Kubas A, Khodri M, Trepo C, Merle P. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French phase II RTF-1 trial. Int J Radiat Oncol Biol Phys. 2006;66(4):1152–8.
Article
Google Scholar
Ducat D, Zheng Y. Aurora kinases in spindle assembly and chromosome segregation. Exp Cell Res. 2004;301(1):60–7.
Article
CAS
Google Scholar
Yan M, Wang C, He B, Yang M, Tong M, Long Z, Liu B, Peng F, Xu L, Zhang Y, et al. Aurora-A Kinase: a potent oncogene and target for cancer therapy. Med Res Rev. 2016;36(6):1036–79.
Article
Google Scholar
D’Assoro AB, Haddad T, Galanis E. Aurora-A Kinase as a promising therapeutic target in cancer. Front Oncol. 2016;5:295.
Article
Google Scholar
Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res. 2004;10(6):2065–71.
Article
CAS
Google Scholar
Wang R, Wang JH, Chu XY, Geng HC, Chen LB. Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance. Clin Biochem. 2009;42(7–8):641–7.
Article
CAS
Google Scholar
Gao P, Wang R, Shen JJ, Lin F, Wang X, Dong K, Zhang HZ. Hypoxia-inducible enhancer/alpha-fetoprotein promoter-driven RNA interference targeting STK15 suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cancer Sci. 2008;99(11):2209–17.
Article
CAS
Google Scholar
Zhang K, Chen J, Chen D, Huang J, Feng B, Han S, Chen Y, Song H, De W, Zhu Z, et al. Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway. Oncotarget. 2014;5(24):12916–35.
PubMed
PubMed Central
Google Scholar
McBride WH, Pajonk F, Chiang CS, Sun JR. NF-kappa B, cytokines, proteasomes, and low-dose radiation exposure. Mil Med. 2002;167(2 Suppl):66–7.
PubMed
Google Scholar
Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol. 1999;19(8):5785–99.
Article
CAS
Google Scholar
Sonenshein GE. Rel/NF-kappa B transcription factors and the control of apoptosis. Semin Cancer Biol. 1997;8(2):113–9.
Article
CAS
Google Scholar
Chen C, Edelstein LC, Gélinas C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol. 2000;20(8):2687–95.
Article
Google Scholar
Briassouli P, Chan F, Savage K, Reis-Filho JS, Linardopoulos S. Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha. Cancer Res. 2007;67(4):1689–95.
Article
CAS
Google Scholar
Kufer TA, Nigg EA, Silljé HH. Regulation of Aurora-A kinase on the mitotic spindle. Chromosoma. 2003;112(4):159–63.
Article
CAS
Google Scholar
Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 2003;22(4):451–64.
Article
Google Scholar
Landen CN Jr, Lin YG, Immaneni A, Deavers MT, Merritt WM, Spannuth WA, Bodurka DC, Gershenson DM, Brinkley WR, Sood AK. Overexpression of the centrosomal protein Aurora-a kinase is associated with poor prognosis in epithelial ovarian cancer patients. Clin Cancer Res. 2007;13(14):4098–104.
Article
CAS
Google Scholar
Tanaka E, Hashimoto Y, Ito T, Okumura T, Kan T, Watanabe G, Imamura M, Inazawa J, Shimada Y. The clinical significance of Aurora-a/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin Cancer Res. 2005;11(5):1827–34.
Article
CAS
Google Scholar
Mobley A, Zhang S, Bondaruk J, Wang Y, Majewski T, Caraway NP, Huang L, Shoshan E, Velazquez-Torres G, Nitti G, et al. Aurora Kinase A is a biomarker for bladder cancer detection and contributes to its aggressive behavior. Sci Rep. 2017;7:40714.
Article
CAS
Google Scholar
Zhang H, Chen X, Jin Y, Liu B, Zhou L. Overexpression of Aurora-A promotes laryngeal cancer progression by enhancing invasive ability and chromosomal instability. Eur Arch Otorhinolaryngol. 2012;269(2):607–14.
Article
Google Scholar
Nadler Y, Camp RL, Schwartz C, Rimm DL, Kluger HM, Kluger Y. Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer. Clin Cancer Res. 2008;14(14):4455–62.
Article
CAS
Google Scholar
Wang XX, Liu R, Jin SQ, Fan FY, Zhan QM. Overexpression of Aurora-a kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Res. 2006;16(4):356–66.
Article
CAS
Google Scholar
Wang X, Dong L, Xie J, Tong T, Zhan Q. Stable knockdown of Aurora-a by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis. Cancer Biol Ther. 2009;8(19):1852–9.
Article
CAS
Google Scholar
Tanaka H, Nakashiro K, Iwamoto K, Tokuzen N, Fujita Y, Shirakawa R, Oka R, Goda H, Hamakawa H. Targeting Aurora kinase a suppresses the growth of human oral squamous cell carcinoma cells in vitro and in vivo. Oral Oncol. 2013;49(6):551–9.
Article
CAS
Google Scholar
Maimaiti Y, Jie T, Jing Z, Changwen W, Pan Y, Chen C, Tao H. Aurora kinase A induces papillary thyroid cancer lymph node metastasis by promoting cofilin-1 activity. Biochem Biophys Res Commun. 2016;473(1):212–8.
Article
CAS
Google Scholar
Wang LH, Xiang J, Yan M, Zhang Y, Zhao Y, Yue CF, Xu J, Zheng FM, Chen JN, Kang Z, et al. The mitotic kinase Aurora-a induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway. Cancer Res. 2010;70(22):9118–28.
Article
CAS
Google Scholar
Sun JM, Yang LN, Xu H, Chang B, Wang HY, Yang G. Inhibition of Aurora a promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells. Am J Cancer Res. 2015;5(3):1133–45.
CAS
PubMed
PubMed Central
Google Scholar
Yang H, He L, Kruk P, Nicosia SV, Cheng JQ. Aurora-a induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer. 2006;119(10):2304–12.
Article
CAS
Google Scholar
Ma Y, Yang J, Wang R, Zhang Z, Qi X, Liu C, Ma M. Aurora-a affects radiosenstivity in cervical squamous cell carcinoma and predicts poor prognosis. Oncotarget. 2017;8(19):31509–20.
Article
Google Scholar
Venkataraman S, Alimova I, Tello T, Harris PS, Knipstein JA, Donson AM, Foreman NK, Liu AK, Vibhakar R. Targeting Aurora kinase a enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells. J Neuro-Oncol. 2012;107(3):517–26.
Article
CAS
Google Scholar
Cui SY, Huang JY, Chen YT, Song HZ, Huang GC, De W, Wang R, Chen LB. The role of Aurora a in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma. Cell Cycle. 2013;12(17):2849–66.
Article
CAS
Google Scholar
Benten D, Keller G, Quaas A, Schrader J, Gontarewicz A, Balabanov S, Braig M, Wege H, Moll J, Lohse AW, et al. Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model. Neoplasia. 2009;11(9):934–44.
Article
CAS
Google Scholar
Chefetz I, Holmberg JC, Alvero AB, Visintin I, Mor G. Inhibition of Aurora-a kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway. Cell Cycle. 2011;10(13):2206–14.
Article
CAS
Google Scholar
Wu CC, Yu CT, Chang GC, Lai JM, Hsu SL. Aurora-a promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells. Biochem Biophys Res Commun. 2011;405(2):168–72.
Article
CAS
Google Scholar
Linardopoulos S. Aurora-a kinase regulates NF-kappaB activity: lessons from combination studies. J Buon. 2007;12(Suppl 1):S67–70.
PubMed
Google Scholar
Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.
Article
CAS
Google Scholar
Bai M, Ma X, Li X, Wang X, Mei Q, Li X, Wu Z, Han W. The accomplices of NF-κB Lead to Radioresistance. Curr Protein Pept Sci. 2015;16(4):279–94.
Article
CAS
Google Scholar